AS SEEN IN
Recent Posts
Focused Behavioral Counseling for Patients on GLP-1s
In my 40+ years as an obesity medicine physician specialist, my entire counseling philosophy and weight management program approach have been rooted in behavior change research related to diet, physical activity, sleep, stress and body image. Obesity medication and bariatric surgery were prescribed as an adjunct to lifestyle counseling. This traditional paradigm is now being…
Managing Persistence Problems -Starting and Stopping GLP-1 Medications
Most people don’t like taking medications – especially longterm. In fact, medication fatigue where individuals stop taking a new medication, like a statin or blood pressure pill, is commonplace. But the number of individuals stopping GLP-1 medications is especially concerning as studies show that over 50% of GLP-1 users discontinue the medication by 1 year…
Can Treating Obesity Improve Women’s Health and Fertility?
I recently had the exciting opportunity to educate gynecologists and fertility specialists throughout India on the role of semaglutide in women’s reproductive health. This allowed me to take a deep dive into the research and medical data answering the question: can obesity treatments improve women’s health outcomes and fertility rates? The answer is a resounding…
‘Treat to Target’ Considerations in Obesity Care
As the field of obesity medicine matures, clinicians and patients are asking: “What is the treatment target?” achievement of a targeted percentage weight loss? improved body mass index (BMI) or waist circumference? better function and quality of life? remission of weight-related complications? ability to taper or discontinue medications for other chronic disease treatments? or –…